Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.
Corianò M, Tommasi C, Dinh ATL, Needham J, Aziz H, Joharatnam-Hogan N, Cunningham N, Waterhouse J, Sun M, Turkes F, Pellegrino B, McGrath S, Okines A, Parton M, Turner N, Johnston S, Musolino A, Ring A, Battisti NML. Corianò M, et al. Among authors: turkes f. Breast Cancer Res Treat. 2024 Aug;206(3):603-614. doi: 10.1007/s10549-024-07336-4. Epub 2024 May 14. Breast Cancer Res Treat. 2024. PMID: 38743174
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE.
Cartwright E, Slater S, Saffery C, Tran A, Turkes F, Smith G, Aresu M, Kohoutova D, Terlizzo M, Zhitkov O, Rana I, Johnston EW, Sanna I, Smyth E, Mansoor W, Fribbens C, Rao S, Chau I, Starling N, Cunningham D. Cartwright E, et al. Among authors: turkes f. ESMO Open. 2024 Apr;9(4):102971. doi: 10.1016/j.esmoop.2024.102971. Epub 2024 Mar 21. ESMO Open. 2024. PMID: 38518549 Free PMC article. Clinical Trial.
Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study.
Turkes F, Bryant A, Begum R, Davidson M, Kalaitzaki E, Aresu M, Lazaro-Alcausi R, Bryant J, Rana I, Chua S, Aronson L, Hulkki-Wilson S, Fribbens C, Watkins D, Rao S, Starling N, Cunningham D, Chong IY, Chau I. Turkes F, et al. Curr Oncol. 2022 Mar 22;29(4):2174-2184. doi: 10.3390/curroncol29040176. Curr Oncol. 2022. PMID: 35448150 Free PMC article.
Targeting the immune milieu in gastrointestinal cancers.
Turkes F, Mencel J, Starling N. Turkes F, et al. J Gastroenterol. 2020 Oct;55(10):909-926. doi: 10.1007/s00535-020-01710-x. Epub 2020 Aug 3. J Gastroenterol. 2020. PMID: 32748171 Free PMC article. Review.
Contemporary Tailored Oncology Treatment of Biliary Tract Cancers.
Turkes F, Carmichael J, Cunningham D, Starling N. Turkes F, et al. Gastroenterol Res Pract. 2019 Dec 18;2019:7698786. doi: 10.1155/2019/7698786. eCollection 2019. Gastroenterol Res Pract. 2019. PMID: 31929787 Free PMC article. Review.